News | MRI Breast | February 21, 2017

Screening MRI Benefits Women at Average Risk of Breast Cancer

Breast MRI used in German study finds an additional 15.5 cancers per 1,000 women

Radiology journal, breast MRI screening, average risk women, breast cancer

Images in a 55-year-old screening participant. (a, b) Normal digital full-field mediolateral oblique (a) and craniocaudal (b) mammograms (BI-RADS category 1) show a heterogeneously dense breast (ACR category C). (c) Screening ultrasound image shows normal findings (BI-RADS category 1). (d) MR-guided biopsy enabled us to confirm the presence of an invasive high-grade triple-negative cancer (no special type [NST], pT1b, N0, M0). (d) Breast MR image shows a suspicious enhancing mass (arrow) in the left breast (BI-RADS category 5). Image courtesy of the Radiological Society of North America.

February 21, 2017 — Magnetic resonance imaging (MRI) screening improves early diagnosis of breast cancer in all women, not only those at high risk, according to a new study from Germany published online in the journal Radiology.

MRI has long been known as an effective breast cancer screening modality that offers better sensitivity than mammography and ultrasound. Currently, guidelines reserve breast MRI screening for women who have a strong family history or other specific breast cancer risk factors. MRI screening has not been considered necessary for women at average risk, and there has been resistance to expansion of MRI into this population due, in part, to concern over higher costs.

However, with breast cancer remaining a major cause of cancer death in women, there is good reason to pursue the search for improved screening methods, according to the study’s lead author, Christiane Kuhl, M.D., chair of the Department of Radiology at RWTH Aachen University in Aachen, Germany.

Between 2005 and 2013, Kuhl and colleagues studied breast MRI’s impact on 2,120 women, ages 40 to 70, with less than a 15 percent lifetime risk of breast cancer. The women had normal screening mammograms and, in the case of those with dense breast tissue, normal screening ultrasound. Breast MRI detected 60 additional breast cancers, including 40 invasive cancers, for an overall supplemental cancer detection rate of 15.5 per 1,000 women. Of the 60 cancers detected in the study group over the observation period (7,007 screening rounds), 59 were found only using MRI, one was found also by mammography, and none by mammography or ultrasound alone.

According to Kuhl, the results suggest that MRI can serve as a useful supplemental screening tool for women at average risk, especially those with dense mammographic tissue, and that MRI is superior to supplemental ultrasound for this purpose.

The results also highlight the ability of MRI in the detection of more aggressive types of cancer.

“The faster a cancer grows and the better it is in seeding metastases, the better will it be picked up early by MRI,” Kuhl said. “In our cohort, cancers found by MRI alone exhibited features of rapid growth at pathology.”

This ability is especially important in women with dense breast tissue in which aggressive cancers may be missed on mammography. Left undetected, these cancers will grow to become clinically palpable cancers, also known as interval cancers. The new study showed that, consistent with previous research, breast MRI can depict these rapidly growing cancers with high reliability.

According to Kuhl, interval cancers exhibit an adverse biologic profile and are the main driver of breast cancer mortality. Additional cancers detected by MRI screening in the study had a skewed distribution towards a higher-than-normal prevalence or incidence of rapidly growing (grade 3) cancers.

“The interval cancer rate in our study was zero percent. Not a single cancer was undetected that became palpable,” she said. “This suggests that MRI finds breast cancers that also mammography would find, but MRI detects them earlier, and it finds the cancers which, if MRI had not been done, would have progressed to interval cancers.”

For more information: www.radiology.rsna.org

References

Kuhl, C.K., Strobel, K., Bieling, H., Leutner, C., et al. "Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer," Radiology. Published online Feb. 21, 2017. DOI: 10.1148/radiol.2016161444

Related Content

 Prostate cancer MRI
News | Clinical Trials | November 15, 2019
November 15, 2019 — Theragnostics, which is developing innovative radiopharm
An image on Brigham and Women's Hospital's 7T MRI system

An image on Brigham and Women's Hospital's 7T MRI system. Image courtesy of Brigham and Women's Hospital

News | Magnetic Resonance Imaging (MRI) | November 13, 2019
November 13, 2019 — Increased immune system activity along the surface of the brain, or meningeal inflammation, may b
 Mammography doctor
News | Breast Imaging | November 12, 2019
November 12, 2019 — Geisinger has partnered with...
Image by Dr. Manuel González Reyes from Pixabay

Image by Dr. Manuel González Reyes from Pixabay 

News | SPECT Imaging | November 08, 2019
November 8, 2019 — Using ground-breaking technology, researchers at the...
This chest X-ray of a patient being treated for e-cigarette or vaping-associated lung injury shows lung opacities, densities and whitish cloud-like areas which are typically seen with unusual pneumonias, fluid in lungs or lung inflammation. Image courtesy of Intermountain Healthcare

This chest X-ray of a patient being treated for e-cigarette or vaping-associated lung injury shows lung opacities, densities and whitish cloud-like areas which are typically seen with unusual pneumonias, fluid in lungs or lung inflammation. Image courtesy of Intermountain Healthcare

News | Clinical Trials | November 08, 2019
November 8, 2019 — As the outbreak of lung injuries and deaths associated with e-cigarettes, or...
Unlike other technologies for imaging the placenta, pCASL MRI can distinguish maternal blood from fetal blood

Image courtesy of Pixabay

News | Clinical Trials | November 07, 2019
November 7, 2019 — A new imaging technique to track
Kubtec has made the Marcum Tech Top 40 (TT40) list of fastest growing technology companies in Connecticut
News | Radiology Business | November 06, 2019
November 6, 2019 — The Connecticut Technology Council (CTC) and...
The U.S. market is unique in that it formed over 55 percent of the global market in 2018

The U.S. market is unique in that it formed over 55 percent of the global market in 2018.

Feature | Mammography | October 30, 2019 | By Imogen Fitt
When breast imaging comes to mind, mammography is the undisputed current modality of choice.